凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CASI 凯信远达

退市 08-31 17:29:51 EDT

0.2075

+0.0000

0.00%

最高0.2075	最低0.2075	成交量0.00
今开0.2075	昨收0.2075	日振幅0.00%
总市值426.38万	流通市值193.70万	总股本2,055万
成交额305.79万	换手率0.00%	流通股本933.47万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CASI","market":"US","secType":"STK","nameCN":"凯信远达","latestPrice":0.2075,"timestamp":1772053200000,"preClose":0.2075,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":9334700,"shares":20548273,"eps":-2.984515,"marketStatus":"退市","change":0,"latestTime":"08-31 17:29:51 EDT","open":0.2075,"high":0.2075,"low":0.2075,"amount":3057913.3961347397,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.984515,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":834552000000,"exchange":"NASDAQ","adjPreClose":0.2075,"volumeRatio":0},"requestUrl":"/m/hq/s/CASI","defaultTab":"news","newsList":[{"id":"2614361760","title":"凯信远达股价重挫63.20% 市值跌382.3万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614361760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614361760?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:33","pubTimestamp":1772029985,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时33分，凯信远达股票出现波动，股价大幅跳水63.20%。截至发稿，该股报0.294美元/股，成交量92.6983万股，换手率4.51%，振幅7.20%。最近的财报数据显示，该股实现营业收入3.08百万美元，净利润-10.88百万美元，每股收益-0.68美元，毛利706000.00美元，市盈率-0.10倍。凯信远达股票所在的生物技术行业中，整体跌幅为0.16%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223305a71e8d6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223305a71e8d6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139","CASIF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157320592","title":"凯信远达预计其普通股将在OTC Markets集团运营的场外市场挂牌交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1157320592","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157320592?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:17","pubTimestamp":1772029048,"startTime":"0","endTime":"0","summary":"凯信远达（CASI Pharmaceuticals）近日宣布，公司预计其普通股将在OTC Markets集团运营的场外交易市场（OTC市场）获得报价。这一举措标志着公司股票交易平台的重要转变。\nOTC市场作为非交易所交易平台，为投资者提供了更灵活的交易渠道。凯信远达此次调整旨在拓宽股票流动性，吸引更广泛的投资群体。公司表示将继续遵守相关市场监管规定，确保股东利益得到充分保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CASIF","CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518208822","title":"凯信远达盘中异动 股价大涨5.45%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518208822?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:26","pubTimestamp":1741624003,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时26分，凯信远达股票出现异动，股价快速拉升5.45%。截至发稿，该股报2.32美元/股，成交量3699股，换手率0.02%，振幅4.55%。凯信远达股票所在的生物技术行业中，整体涨幅为0.43%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100264398a2c0fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100264398a2c0fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517944039","title":"凯信远达盘中异动 股价大涨8.77%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517944039?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:30","pubTimestamp":1741192214,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时30分，凯信远达股票出现波动，股价快速上涨8.77%。截至发稿，该股报2.48美元/股，成交量1727股，换手率0.01%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体涨幅为1.12%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003014abe9d509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003014abe9d509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516729652","title":"凯信远达盘中异动 下午盘快速上涨9.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516729652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516729652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:46","pubTimestamp":1741027600,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时46分，凯信远达股票出现波动，股价大幅拉升9.33%。截至发稿，该股报2.46美元/股，成交量491股，换手率0.00%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体涨幅为0.59%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024640abe67bdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024640abe67bdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514103017","title":"凯信远达盘中异动 大幅跳水6.48%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514103017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514103017?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:43","pubTimestamp":1740505381,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时43分，凯信远达股票出现异动，股价快速跳水6.48%。截至发稿，该股报2.26美元/股，成交量7485股，换手率0.05%，振幅3.72%。凯信远达股票所在的生物技术行业中，整体涨幅为0.59%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226014302abdcaa8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226014302abdcaa8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512198750","title":"凯信远达上涨2.2%，报2.555美元/股，总市值3958.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512198750","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512198750?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:42","pubTimestamp":1739900566,"startTime":"0","endTime":"0","summary":"2月19日，凯信远达盘中上涨2.2%，截至01:42，报2.555美元/股，成交5294.0美元，总市值3958.35万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。大事提醒：3月27日，凯信远达将披露2024财年年报。资料显示，凯信远达医药公司是一家美国纳斯达克上市的生物医药公司,致力于在血液肿瘤领域为中国患者提供先进的疾病治疗方案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/19014248243218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511572054","title":"凯信远达上涨2.36%，报2.6美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2511572054","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511572054?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:46","pubTimestamp":1739479578,"startTime":"0","endTime":"0","summary":"2月14日，凯信远达(CASI)盘中上涨2.36%，截至04:46，报2.6美元/股，成交1.68万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。大事提醒：3月27日，凯信远达将披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/14044648151014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510861944","title":"凯信远达上涨5.69%，报2.6美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861944","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510861944?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:35","pubTimestamp":1739201743,"startTime":"0","endTime":"0","summary":"2月10日，凯信远达(CASI)盘中上涨5.69%，截至23:35，报2.6美元/股，成交2147.0美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。大事提醒：3月27日，凯信远达将披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/10233548064213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510861317","title":"凯信远达盘中异动 早盘股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510861317?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:35","pubTimestamp":1739201726,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时35分，凯信远达股票出现波动，股价急速上涨5.69%。截至发稿，该股报2.60美元/股，成交量832股，换手率0.01%，振幅3.46%。凯信远达股票所在的生物技术行业中，整体跌幅为0.04%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210233526961e0da1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210233526961e0da1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509774208","title":"凯信远达盘中异动 早盘股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509774208?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:54","pubTimestamp":1738940098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时54分，凯信远达股票出现波动，股价大幅跳水6.34%。截至发稿，该股报2.51美元/股，成交量497股，换手率0.00%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体涨幅为0.10%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225458abc63007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225458abc63007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509200461","title":"凯信远达下跌2.41%，报2.489美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2509200461","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509200461?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:52","pubTimestamp":1738867940,"startTime":"0","endTime":"0","summary":"2月7日，凯信远达(CASI)盘中下跌2.41%，截至02:52，报2.489美元/股，成交1.03万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。大事提醒：3月27日，凯信远达将披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/07025248002875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509272343","title":"凯信远达盘中异动 早盘股价大跌5.10%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509272343?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:35","pubTimestamp":1738852504,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时35分，凯信远达股票出现波动，股价急速下挫5.10%。截至发稿，该股报2.42美元/股，成交量151股，换手率0.00%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体跌幅为0.19%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223504987c8f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223504987c8f5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509280413","title":"凯信远达盘中异动 早盘急速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509280413?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:12","pubTimestamp":1738768366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时12分，凯信远达股票出现异动，股价大幅下挫5.88%。截至发稿，该股报2.40美元/股，成交量2405股，换手率0.02%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体涨幅为1.20%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231246961910f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231246961910f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508450260","title":"凯信远达盘中异动 早盘急速上涨6.36%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508450260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508450260?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:56","pubTimestamp":1738680990,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时56分，凯信远达股票出现波动，股价大幅上涨6.36%。截至发稿，该股报2.51美元/股，成交量5169股，换手率0.03%，振幅4.24%。凯信远达股票所在的生物技术行业中，整体涨幅为0.63%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225630987a4ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225630987a4ec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508172450","title":"凯信远达上涨3.39%，报2.44美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2508172450","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508172450?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:55","pubTimestamp":1738680921,"startTime":"0","endTime":"0","summary":"2月4日，凯信远达(CASI)盘中上涨3.39%，截至22:55，报2.44美元/股，成交4557.0美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。大事提醒：3月27日，凯信远达将披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/04225547949819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508123458","title":"凯信远达盘中异动 临近午盘大幅跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508123458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508123458?lang=zh_cn&edition=full","pubTime":"2025-02-04 00:55","pubTimestamp":1738601739,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日00时55分，凯信远达股票出现异动，股价大幅跳水5.05%。截至发稿，该股报2.35美元/股，成交量1.4063万股，换手率0.09%，振幅8.89%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体跌幅为0.39%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204005540a238263b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204005540a238263b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507961051","title":"凯信远达盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507961051?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:51","pubTimestamp":1738335077,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时51分，凯信远达股票出现波动，股价快速下挫5.01%。截至发稿，该股报2.37美元/股，成交量1841股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为1.46%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312251179614ed9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312251179614ed9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507677553","title":"凯信远达上涨6.34%，报2.515美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2507677553","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507677553?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:48","pubTimestamp":1738266504,"startTime":"0","endTime":"0","summary":"1月31日，凯信远达(CASI)盘中上涨6.34%，截至03:48，报2.515美元/股，成交2.1万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/31034847911164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","CASI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507677441","title":"凯信远达盘中异动 急速拉升6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507677441","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507677441?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:48","pubTimestamp":1738266480,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时48分，凯信远达股票出现波动，股价快速上涨6.34%。截至发稿，该股报2.52美元/股，成交量8807股，换手率0.06%，振幅5.92%。凯信远达股票所在的生物技术行业中，整体涨幅为0.18%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/us/2025-01-31/doc-inehuxcv1159952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","CASI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.casipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.915},{"period":"ytd","weight":-0.7559}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"凯信远达医药公司于1991年注册成立，是一家在开曼群岛注册成立的豁免公司。该公司是一家生物制药公司，专注于在中国、美国和世界各地开发和商业化创新疗法和医药产品。公司打造了一家完全一体化、世界一流的生物制药公司，致力于创新和其他治疗产品的成功开发和商业化。公司业务发展战略目前的重点是通过许可获得额外的靶向药物和免疫肿瘤疗法，这将扩大血液学/肿瘤学特许经营权。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.166552},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.036298},{"month":3,"riseRate":0.310345,"avgChangeRate":-0.000942},{"month":4,"riseRate":0.37931,"avgChangeRate":0.030827},{"month":5,"riseRate":0.241379,"avgChangeRate":0.04909},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.032316},{"month":7,"riseRate":0.266667,"avgChangeRate":-0.055599},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.00385},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.001431},{"month":10,"riseRate":0.6,"avgChangeRate":0.088727},{"month":11,"riseRate":0.366667,"avgChangeRate":0.020646},{"month":12,"riseRate":0.233333,"avgChangeRate":-0.100731}],"exchange":"NASDAQ","name":"凯信远达","nameEN":"CASI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯信远达,CASI,凯信远达股票,凯信远达股票老虎,凯信远达股票老虎国际,凯信远达行情,凯信远达股票行情,凯信远达股价,凯信远达股市,凯信远达股票价格,凯信远达股票交易,凯信远达股票购买,凯信远达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}